How Does The Scottish Medicines Consortium Assess The Value Of Orphan And Ultra-Orphan Drugs?
Sign Up to like & getrecommendations! Published in 2017 at "Value in Health"
DOI: 10.1016/j.jval.2017.08.964
Abstract: Objectives: In Germany the reimbursement of inpatient factor products is negotiated between hospitals and statutory sick funds on region or on hospitals level. The payment for groups of factors or each individual product brand is… read more here.
Keywords: established products; scottish medicines; factor products; value ... See more keywords